Showing results (281-290 of 322) with videos related to

Sort By:
Pageof 33
Science Translational Medicine|December 17, 2025
Dual PI3K/mTOR inhibition is required to combat resistance to CDK4/6 inhibitor and endocrine therapy in PIK3CA-mutant breast cancerCarla L Alves, Leena Karimi, Mikkel G Terp, et al.
International Journal of Cancer|August 11, 2024
Genomic alterations associated with resistance and circulating tumor DNA dynamics for early detection of progression on CDK4/6 inhibitor in advanced breast cancerCharlotte K Kindt, Carla L Alves, Sidse Ehmsen, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 19, 2015
Acquisition of docetaxel resistance in breast cancer cells reveals upregulation of ABCB1 expression as a key mediator of resistance accompanied by discrete upregulation of other specific genes and pathwaysStine Ninel Hansen, David Westergaard, Mathilde Borg Houlberg Thomsen, et al.
Cancer Research|September 10, 2025
SWI/SNF Functions as a Gatekeeper of Enhancer Chromatin Access to Control Progression of Mesenchymal Triple-Negative Breast CancerRikkemaja Isahbell J Møldrup, Mikkel G Terp, Simon T Jakobsen, et al.
Breast Cancer Research : BCR|February 19, 2021
Distinct mechanisms of resistance to fulvestrant treatment dictate level of ER independence and selective response to CDK inhibitors in metastatic breast cancerKamila Kaminska, Nina Akrap, Johan Staaf, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 25, 2013
TIMP1 overexpression mediates resistance of MCF-7 human breast cancer cells to fulvestrant and down-regulates progesterone receptor expressionChristina Bjerre, Lena Vinther, Kirstine C Belling, et al.
Hypertension (Dallas, Tex. : 1979)|September 9, 2022
Quantitative Phosphoproteomics of the Angiotensin AT2-Receptor Signaling Network Identifies HDAC1 (Histone-Deacetylase-1) and p53 as Mediators of Antiproliferation and ApoptosisA Augusto Peluso, Stefan J Kempf, Thiago Verano-Braga, et al.
Frontiers in Oncology|May 9, 2022
Intrinsic Differences in Spatiotemporal Organization and Stromal Cell Interactions Between Isogenic Lung Cancer Cells of Epithelial and Mesenchymal Phenotypes Revealed by High-Dimensional Single-Cell Analysis of Heterotypic 3D Spheroid ModelsMaria L Lotsberg, Gro V Røsland, Austin J Rayford, et al.
Gut Microbes Reports|March 30, 2026
Role of gut microbiome in pathogenesis and treatment of diseases: Multidisciplinary experts' opinion of the Asian Medical Experts Academy (AMEA)Raphaela I Lau, Martin C S Wong, Louis H S Lau, et al.
JCI Insight|October 11, 2019
Enapotamab vedotin, an AXL-specific antibody-drug conjugate, shows preclinical antitumor activity in non-small cell lung cancerLouise A Koopman, Mikkel G Terp, Gijs G Zom, et al.
Pageof 33